GENOCEA BIOSCIENCES, INC. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOCEA BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOCEA BIOSCIENCES, INC. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | A | 12.10 | 6,191 | 74,911 | 6,191 | |
| Feb 24 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | A | 12.10 | 14,397 | 174,204 | 14,397 | |
| Feb 24 2014 | GNCA | GENOCEA BIOSCIENCE ... | Farrell Robert E Jr | VP of Finance & Adm ... | Option Exercise | A | 12.10 | 17,019 | 205,930 | 17,019 | |
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 4,851,958 | 0 | 0 | ||
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 4,099,231 | 0 | 0 | ||
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 9,230,769 | 0 | 0 | ||
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 407,727 | 0 | 1,671,667 | 1.3 M to 1.7 M (+32.26 %) | |
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 344,473 | 0 | 1,263,940 | 919.5 K to 1.3 M (+37.46 %) | |
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 775,694 | 0 | 919,467 | 143.8 K to 919.5 K (+539.53 %) | |
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Buy | P | 12.00 | 143,773 | 1,725,276 | 143,773 | 0 to 143.8 K | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | X | 0.00 | 399,909 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 6,075,152 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 5,836,663 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 8,393,754 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 2,126,923 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | P | 12.00 | 232,820 | 2,793,840 | 2,128,678 | 1.9 M to 2.1 M (+12.28 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 10,781 | 0 | 1,895,858 | 1.9 M to 1.9 M (+0.57 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 510,516 | 0 | 1,885,077 | 1.4 M to 1.9 M (+37.14 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 490,474 | 0 | 1,374,561 | 884.1 K to 1.4 M (+55.48 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 705,356 | 0 | 884,087 | 178.7 K to 884.1 K (+394.65 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 178,731 | 0 | 178,731 | 0 to 178.7 K |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | X | 0.00 | 399,909 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 6,075,152 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 5,836,663 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 8,393,754 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 2,126,923 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | P | 12.00 | 232,820 | 2,793,840 | 2,128,678 | 1.9 M to 2.1 M (+12.28 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 10,781 | 0 | 1,895,858 | 1.9 M to 1.9 M (+0.57 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 510,516 | 0 | 1,885,077 | 1.4 M to 1.9 M (+37.14 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 490,474 | 0 | 1,374,561 | 884.1 K to 1.4 M (+55.48 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 705,356 | 0 | 884,087 | 178.7 K to 884.1 K (+394.65 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 178,731 | 0 | 178,731 | 0 to 178.7 K |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | X | 0.00 | 587,931 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | C | 0.00 | 5,099,196 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | C | 0.00 | 3,207,794 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | C | 0.00 | 8,393,754 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | C | 0.00 | 2,126,923 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | X | 0.00 | 15,852 | 0 | 1,682,037 | 1.7 M to 1.7 M (+0.95 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | C | 0.00 | 428,502 | 0 | 1,666,185 | 1.2 M to 1.7 M (+34.62 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | C | 0.00 | 269,561 | 0 | 1,237,683 | 968.1 K to 1.2 M (+27.84 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | C | 0.00 | 705,357 | 0 | 968,122 | 262.8 K to 968.1 K (+268.44 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | C | 0.00 | 178,732 | 0 | 262,765 | 84 K to 262.8 K (+212.69 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 4,851,958 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 4,099,231 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 9,230,769 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 407,727 | 0 | 1,671,667 | 1.3 M to 1.7 M (+32.26 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 344,473 | 0 | 1,263,940 | 919.5 K to 1.3 M (+37.46 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 775,694 | 0 | 919,467 | 143.8 K to 919.5 K (+539.53 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | P | 12.00 | 143,773 | 1,725,276 | 143,773 | 0 to 143.8 K |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Option Exercise | C | 0.00 | 3,140,414 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Option Exercise | C | 0.00 | 9,253,255 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Buy | P | 12.00 | 250,931 | 3,011,172 | 1,292,415 | 1 M to 1.3 M (+24.09 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Buy | C | 0.00 | 263,900 | 0 | 1,041,484 | 777.6 K to 1 M (+33.94 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Buy | C | 0.00 | 777,584 | 0 | 777,584 | 0 to 777.6 K |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 3.45 | 81,670 | 281,762 | 81,670 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Siber George | Director | Option Exercise | A | 3.45 | 13,568 | 46,810 | 13,568 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 351,866 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 827,917 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 1,388,645 | 0 | 1,388,645 | 0 to 1.4 M |
| Feb 06 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | A | 12.00 | 12,236 | 146,832 | 12,236 | |
| Feb 06 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | A | 12.00 | 11,402 | 136,824 | 11,402 | |
| Feb 06 2014 | GNCA | GENOCEA BIOSCIENCE ... | Farrell Robert E Jr | VP of Finance & Adm ... | Option Exercise | A | 12.00 | 1,409 | 16,908 | 1,409 |